MRI Safety (Tech)-Gadolinium Principles of contrast enhancement and patient safety

Gadolinium Principles of contrast enhancement and patient safety

Video Transcription

Video Summary

The transcript explains gadolinium contrast agents used in MRI, focusing on how they shorten T1 relaxation to make tissues appear brighter. It compares linear and macrocyclic agents, noting macrocyclics are more stable and likely safer. It reviews key risks: allergic reactions, nephrogenic systemic fibrosis in patients with severe kidney disease, and gadolinium deposition in the brain, especially after repeated doses of linear agents. The speaker also discusses off-label use in cardiac MRI, changing regulations in the U.S. and Europe, and the trend toward fewer, more stable contrast agents in future practice.

Keywords

gadolinium contrast agents

MRI T1 relaxation

macrocyclic agents

nephrogenic systemic fibrosis

gadolinium deposition